A customized AbMA test was fabricated for tear MMP-9 quantification in human samples, managing to detect the biomarker in pathologies that involve inflammation of the ocular surface, such as cataracts, glaucoma, meibomian gland dysfunction, allergy, or dry eye. The gene discussed is MMP9; the disease is Keratoconjunctivitis sicca.